Pace Life Sciences LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of ...

In 2024, AI was one of the hottest topics, affecting every corner of nearly every industry. It has continued to become deeply ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an ...

According to CEO: ‘Demand across the industry not meeting our expectations.’ ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

Pozzi, a professional in the field of packaging systems, has more than twenty years of experience.

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...

New approval brings the medicine to an earlier treatment setting and a broader patient population.

Schrödinger, a global leader in computational chemistry, has adopted the Sapio Sciences Platform to improve data management, ...

I-MAB completed a workforce reduction as part of a Realignment Plan aimed at optimizing its operations following the pipeline reprioritization. The company reduced its workforce by approximately 27% ...

The approval was based on results from the TROPION-Breast01 Phase III trial.